Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Canadian Pacific Kansas City
CP
$78.3B
| $488M | 0.17% |
6,202,848
+429,576
| +7% | +$34M |
|
102
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
| $479M | 0.16% |
2,961,891
-158,077
| -5% | -$26.5M |
|
103
Parker-Hannifin
PH
$121B
| $456M | 0.15% |
509,577
-61,693
| -11% | -$58.4M |
|
104
Crown Castle
CCI
$33.4B
| $453M | 0.15% |
5,576,947
+70,367
| +1% | +$6.06M |
|
105
iShares Global Consumer Staples ETF
KXI
$1.07B
| $448M | 0.15% |
6,678,424
+645,775
| +11% | +$44.4M |
|
|
106
Banco Santander
SAN
$202B
| $446M | 0.15% |
39,517,855
-57,347,736
| -59% | -$684M |
|
|
PBEU
107
Portfolio Building Block European Banks Index ETF
PBEU
$463M
| $436M | 0.15% |
+15,876,488
| New | +$462M |
|
108
Vanguard FTSE Europe ETF
VGK
$30.8B
| $414M | 0.14% |
5,017,454
+45,233
| +0.9% | +$3.89M |
|
109
Southern Copper
SCCO
$145B
| $397M | 0.13% |
2,331,611
-251,753
| -10% | -$46.1M |
|
110
Vale
VALE
$63.8B
| $358M | 0.12% |
22,519,675
+922,299
| +4% | +$14.4M |
|
111
Rockwell Automation
ROK
$52.4B
| $333M | 0.11% |
927,088
+69,559
| +8% | +$27.4M |
|
112
Dover
DOV
$27.5B
| $332M | 0.11% |
1,594,920
-15,221
| -0.9% | -$3.25M |
|
113
Norfolk Southern
NSC
$75B
| $332M | 0.11% |
1,155,414
+14,424
| +1% | +$4.29M |
|
|
NVO
114
Novo Nordisk
NVO
$228B
| $332M | 0.11% |
9,021,103
-763,119
| -8% | -$36.2M |
|
115
iShares Global Tech ETF
IXN
$8.34B
| $308M | 0.1% |
3,077,924
+24,696
| +0.8% | +$2.61M |
|
116
Invesco KBW Bank ETF
KBWB
$6.83B
| $306M | 0.1% |
3,864,794
+296,580
| +8% | +$24.8M |
|
117
HDFC Bank
HDB
$124B
| $304M | 0.1% |
12,229,278
+378,516
| +3% | +$11.8M |
|
118
American Tower
AMT
$81.3B
| $300M | 0.1% |
1,736,413
-43,120
| -2% | -$7.76M |
|
119
Canadian National Railway
CNI
$76.9B
| $260M | 0.09% |
2,534,484
+254,706
| +11% | +$26.3M |
|
120
US Bancorp
USB
$98B
| $254M | 0.09% |
4,878,204
-21,959
| -0.4% | -$1.21M |
|
121
Petrobras
PBR
$123B
| $245M | 0.08% |
11,830,951
-2,152,030
| -15% | -$34.4M |
|
122
Honda
HMC
$39.9B
| $245M | 0.08% |
10,093,465
-438,784
| -4% | -$12.7M |
|
123
Canadian Imperial Bank of Commerce
CM
$108B
| $241M | 0.08% |
2,542,650
+440,035
| +21% | +$42.1M |
|
124
iShares US Pharmaceuticals ETF
IHE
$1.48B
| $240M | 0.08% |
2,767,359
-58,285
| -2% | -$5.1M |
|
125
Itaú Unibanco
ITUB
$93B
| $240M | 0.08% |
28,614,724
+74,687
| +0.3% | +$625K |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.